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INTRODUCTION 
Diabetes mellitus is a very common chronic disease. 
Although both genetic & environmental factors appear to 
play a role, the cause of diabetes mellitus is still not clear. 
A large number of studies have demonstrated that 
oxidative stress & nonenzymatic protein glycation are 
closely associated with the development of diabetes 
mellitus (1, 2). Diabetes mellitus is a heterogeneous 
metabolic disorder characterized by altered carbohydrate, 
lipid & protein metabolism (3). Diospyros peregrina  
(Ebenaceae) is a small middle sized tree, glabrous except 
the younger parts with numerous spreading branches, 
forming an impenetrable shady head, which grows 
luxuriantly in the plains of coastal west Bengal. Ripe fruits 
are edible with ethnomedicinal significance as tonics & 
aphrodisiac (4). The plant Diospyros peregrine  belonging 
to family Ebenaceae  , known as Gab & Kalatendu in 
vernacular has been used as an antidiarrhoeal, aphrodisiac, 
anti snake bite & as a tonic in the ancient Indian 
medicine(5). Diospyros peregrine (syn. Malabanica  Desr, 
D. embryopteris pers.) or family Ebanaceae is a well 
known medicinal plant, the bark of which is used in the 
treatment  of dysentery & intermittent fevers(6,7). 
MATERIALS AND METHODS 
 Plant Material 
The leaves of Diospyros peregrina Gurke were collected 
from Forest Research Institute garden, Dehradun, India, in 
month of October 2008. The identification of the plant was 
verified by Dr. P. B. Singh, Scientist and Head of Regional 
Research Institute (Ay.), Jhansi. A voucher specimen 
(Accession no. 401) of the authenticated Diospyros 
peregrina Gurke has been deposited in the herbarium of 
the Institute. 
Drugs and Chemicals 
Alloxan Hydrate (ALX) was purchased from CDH 
Chemicals (New Delhi, India), while Metformin 
Hydrochloride (MET) was a gift sample from PDP 
Ltd.[Indore (M.P.), India]. Glucose Oxidase Peroxidase 
glucose estimate kit was purchased from (Span Diagnostic 
Ltd., Surat, India). All remaining chemicals used in the 
experiment were of highest grade commercially available. 
Animals 
 Healthy adult albino rats of Wistar strain weighing about 
150-200g of either sex between 2-3 months of age were 
selected as the animal model. Female Swiss mice (20-25g) 
were used for acute toxicity studies. They were housed in 
group in polypropylene cages, maintained under standard 
conditions (12:12h light: dark cycle; 25±3˚C; 40-60% 
humidity) and maintained with free access to standard rat 
pellet diet (Hindustan Lever Ltd., Mumbai, India) and 
water made available ad libitum. Eighteen hours before 
experimentation, food was withdrawn but water remained 
ad libitum. All experimental protocols were approved by 
Institutional Animal Ethical committee of the Institute 
(approved by CPCSEA Regd. No. 716/02/a/CPCSEA). 
Acute toxicity Study  
Healthy female swiss mice, starved 3-4 hours were 
subjected to acute toxicity studies to determine the safe 
dose by acute toxic class method of oral toxicity as per 
OECD 423 guidelines(8). Different dose level of 5, 50, 300, 
2000 mg, the mice were observed continuously for 2 hours 
for behavioural, neurological and autonomic profile and, 
after a period of 24 and 72 hours, for any lethality, 
moribund state or death. No death was observed at highest 
dose. The doses selected were 100, 200 and 400 mg/kg.   
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Assessment of serum glucose 
Serum glucose was estimated in overnight fasted rats 48 
hour after the administration of alloxan. Blood was 
withdrawn from the retro orbital plexus on 0, 1, 2, and 3 
hour after administration of the DPLE and clear serum 
were obtained after centrifugation at 3000 rpm for 10 
minutes. Fasting serum glucose level was estimated using 
a Glucose Oxidase – Peroxidase glucose estimate kit (Span 
Diagnostic Ltd., Surat, India) (9).  
EXPERIMENTAL PROCEDURE 
Effect of DPLE on blood glucose in normal rats: 
The Swiss albino Wistar rats were divided into five 
different groups of six animals in each group. Rats were 
fasted overnight (18 hour) and optimum care was 
exercised to avoid coprophagia. Vehicle treated group 
received 0.5% Sodium CMC in distilled water while 
extract treated group received DPLE 100, 200, 400 mg/kg  
intragastrically, while standard treated group received 
metformin 500 mg/kg intragastrically. The assessment of 
blood glucose was carried out on 0, 1, 2, and 3 hour after 
administration of drug. 
Effect of DPLE on oral glucose tolerance test (OGTT) 
in normal rats : 
The oral glucose tolerance test (10) was performed in 
overnight fasted (18 hour) normal rats. Rats were divided 
into five different groups of six animals in each group. 
Group-I received glucose (4g/kg) and vehicle. Group-II 
received glucose (4g/kg) and DPLE 100 mg/kg. Group-III 
received glucose (4g/kg) and DPLE 200 mg/kg. Group-IV 
received glucose (4g/kg) and DPLE 400 mg/kg. Group-V 
received glucose (4g/kg) and metformin (500 mg/kg). 
Glucose fed orally. Blood was withdrawn from the retro 
orbital plexus (11) at 0, 30, 60 and 120 minutes after glucose 
administration and the serum was estimated for fasting 
glucose level.  
Effect of DPLE on alloxan-induced hyperglycaemia: 
The Swiss albino Wistar rats were divided into six 
different groups of six animals. Rats were fasted overnight 
and optimum care was exercised to avoid caprophagia. 
Non diabetic control group received normal saline while 
diabetic control group received alloxan and vehicle of the 
extract. Extract treated groups received DPLE (100, 200 
and 400 mg/kg, intragastrically) in addition to alloxan. 
Standard treated group received metformin (500 mg/kg, 
intragastrically). The assessment of blood glucose was 
carried out on 0, 1, 2 and 3 hour after administration of 
drug. 
Statistical Analysis  
The data were analyzed with ANOVA by using Dunnett 
multiple comparision test and significance was calculated.  
RESULTS 
Acute toxicity Study  
Acute toxicity studies revealed that extract was safe up to 
dose level of 2000 mg/kg of body weight (limit test). No 
lethality or any toxic reactions or morbidity state were 
observed up to the end of the study period. 
Table 1: Effect of DPLE on Normal glycemic rats 
Groups 
Serum glucose level (mg/dl) 
TIME 
0h 1h 2h 3h 
Group I  
Vehicle 
76.44±1.63 84.25±2.21 82.83±2.50 78.86±2.13 
Group II 
DPLE 100 
76.44±1.63 85.52±1.54 84.53±1.88 86.23±1.80 
Group III 
DPLE 200 
78.43±3.08 79.42±2.61 77.44±2.11 80.56±2.38 
Group IV 
DPLE 400 
74.17±3.01 75.31±1.86 77.44±2.88 79.62±2.01 
Group V 
Metformin  
82.26±3.01 80.70±2.38 79.28±3.21 79.14±3.14 
Values are expressed as mean±SEM, (n=6),   *P< 0.05, compared to vehicle treated group (group I) (Dunnett multiple comparison test). 
 
Alloxan-induced Hyperglycaemia: 
The single intravenous dose of alloxan induced significant 
hyperglycaemia in 48 hours of treatment in the 
experimental rats which was confirmed by the presence of 
high serum glucose level (>200 mg/dl). The rats exhibiting 
serum glucose level less than 200 mg/dl at 0 hour were 
excluded from the study. 
Effect of DPLE on blood glucose in Normal Rats  
One way ANOVA did not show any significant effect of 
DPLE on blood glucose level in normal rats. Neither 
extract nor the standard of metformin (P>0.05) 
significantly affects serum glucose level (table 1). 
Effect DPLE on Oral Glucose Tolerance Test (OGGT)  
One way ANOVA showed significant effect of DPLE on 
OGGT. Dunnett multiple comparison test indicated that 
DPLE (100, 200 and 400 mg/kg) exhibited a significant 
reduction in serum glucose level from up to 120 minutes 
after glucose load and the effect was comparable to that of 
standard antidiabetic drug metformin  (table 2). 
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Figure 1: Graphical representation of DPLE on Normal glycemic rats 
 
Table 2: Effect of DPLE on oral glucose tolerance test 
Groups 
Serum glucose level (mg/dl) 
TIME 
0min 30min 60 min 120 min 
Group I  
Vehicle 
81.67±3.48 156.97±3.54 149.07±2.96    110.08±2.74 
Group II 
DPLE 100 
72.93±1.99 132.30±3.03** 123.35±4.16** 105.34±2.78* 
Group III 
DPLE 200 
75.79±2.89 125.25±2.91** 110.55±3.11**      92.59±2.26* 
Group IV 
DPLE 400 
71.25±2.78 113.31±3.47** 91.43±3.79**      83.69±6.34** 
Group V 
Metformin  
66.38±3.06* 109.07±2.70**        82.68±1.54**        74.11±1.53** 
Values are expressed as mean±SEM, (n=6), 
*P< 0.05 as compared to vehicle treated group (Group I), **P<0.01 compared to vehicle treated group (Group I) (Dunnett 
multiple comparison test). 
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Figure 2: Graphical representation of DPLE on oral glucose tolerance test 
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Effect of DPLE on Alloxan induced Hyperglycaemia in Rats  
One way ANOVA showed significant effect of DPLE on alloxan induced hyperglycaemia in rats.  Dunnett multiple 
comparison test indicated that DPLE (100, 200 and 400 mg/kg) exhibited a significant reduction in the hyperglycaemia in 
alloxan treated animals. The effect of DPLE was comparable to that of standard drug metformin (Table 3). 
Table 3: Effect of DPLE on alloxan induced hyperglycaemia in rats 
Groups 
Serum glucose level (mg/dl) 
TIME 
0h 1h 2h 3h 
Group I 
NC 
81.56±3.14 79.12±2.14 80.89±3.45 80.34±3.45 
Group II 
DC 
357.20±2.16   355.32±2.68   351.41±1.99           356.74±2.95 
Group III 
DPLE 100 
352.43±2.83   341.18±2.51** 330.21±2.23**       321.13±2.68** 
Group IV 
DPLE 200 
348.68±3.63   323.68±3.50**      307.30±2.82**       289.99±2.80** 
Group V 
DPLE 400 
342.27±2.91    297.55±3.40**      259.48±4.54**       227.90±3.79** 
Group VI 
Metformin 
354.19±2.85    280.45±2.97**      212.58±3.81**         190.56±4.92** 
NC = Normal Control 
DC = Diabetic Control 
Values are expressed as mean± SEM, (n=6), 
*P< 0.05 as compared to vehicle treated group (Group II), **P<0.01 compared to vehicle treated group (Group II) 
(Dunnett multiple comparison test). 
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Figure 3: Graphical representation of DPLE on alloxan induced hyperglycaemia in rats 
DISCUSSION 
Currently available drug regimen for management of 
diabetes mellitus has certain drawback (12, 13) and therefore, 
there is need for safer more effective anti- diabetic drugs. 
This study was therefore undertaken to assess anti-
hyperglycaemic properties of Diospyros peregrina plant, 
which have been reported in Ayurveda to be useful in 
diabetes mellitus. It is well documented that alloxan induce 
diabetes by damaging the insulin secreting cells of the 
pancreas leading to hyperglycaemia (14). Excessive hepatic 
glycogenolysis and gluconeogenesis associated with 
decreased utilization of glucose by tissues in the 
fundamental mechanism underlying hyperglycaemia in the 
diabetic state (15). The difference observed between the 
initial and final fasting serum glucose levels of different 
groups in the present investigations revealed a significant 
elevation in blood glucose in the diabetic control (ALX 
treated) group as compared with normal animals at the end 
of the 48 hours after ALX administration. In our study, 
Pawan et al                                     Journal of Drug Delivery & Therapeutics; 2011, 1(1): 60-64    64 
© 2011, JDDT. All Rights Reserved 
treatment with a single dose of the methanolic leaves 
extract of Diospyros peregrina did not showed any 
significantly decrease in the basal glucose level in normal 
rats. Also like the extract, metformin did not affect the 
serum level. This is in accordance with the reports which 
demonstrated that metformin does not produce 
hypoglycaemia in non-diabetic state. 
In glucose loaded normal rats, hypoglycaemia was 
observed at 120 minutes after administration of the DPLE. 
This indicates the efficacy of the extract to control elevated 
blood sugar. Since alloxan selectively destroy β-cells of 
pancreas, we would accept the extract to exert no effect on 
serum glucose concentration in alloxan diabetic rats if the 
mode of action is mediated through insulin production. 
Therefore, the present results suggest that the 
hypoglycaemic effect observed with DPLE appear to 
involve mechanism that does not involve insulin. 
The results further revealed maintenance of blood sugar 
levels in diabetic rats after single dose administration of 
DPLE throughout the period of study. Metformin, used as 
the reference oral hypoglycaemic agent in this study, is a 
biguanide. Generally, the exact mechanism of action of 
biguanides is not clearly understood. Currently, proposed 
mechanism of action include : (1) direct stimulation of 
glycolysis in tissues, with increased glucose removal from 
blood; (2) reduced hepatic and renal gluconeogenesis; (3) 
slowing of glucose absorption from gastrointestinal tract, 
with increase glucose to lactate conversion by enterocytes; 
(4) and reduction of plasma glucagon levels(16). 
Phytochemical studies carried out on the extract revealed 
the presence of phenol and flavonoids, which have been 
reported to have a major role in reducing oxidative stress 
associated with diabetes, which in turn helps the regulation 
of plasma glucose concentration (17). Flavonoids isolated 
from different sources have been documented to show 
anti-hyperglycaemic activity (18). Thus, the significant anti-
diabetic activity of DLPE extract in our study may be 
attributed to the presence of flavonoids in the plant. 
Longer duration studies of Diospyros peregrina and its 
isolated compound are necessary to develop a potent anti-
diabetic drug. 
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